Pharmacy News

Today's Pharmaceutical and Pharmacy News

Daily News Topic:

FDA News

3/12/10 - Boston Scientific wins FDA approval for Express LD iliac stent system

Boston Scientific, a medical device company, has reported that the FDA has approved its Express LD iliac premounted stent system for use in iliac arteries. The Express LD iliac stent is reportedly the first and only low-profile, premounted, balloon-expandable stent approved by the FDA for use in treating iliac artery disease.

3/12/10 - Bovie Medical Corporation Announces Clearance to Market Its ICON VS Electrosurgical Generator

Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced the Company received clearance from the Food and Drug Administration to market its ICON VS electrosurgical generator. The fully digital ICON VS generator has a user-friendly touch-screen interface allowing the surgeon flexibility to choose from a var

3/12/10 - Caraco Pharmaceutical Laboratories launches generic Eloxatin

US-based pharmaceutical company Caraco Pharmaceutical Laboratories has announced the introduction of oxaliplatin injections. These 50mg and 100mg oxaliplatin injections, which are therapeutically equivalent to Eloxatin from Sanofi-Aventis, have received approval from the FDA for Sun Pharma's abbreviated new drug application.

3/12/10 - Eisai says FDA approved new Dacogen dosing

WOODCLIFF LAKE, N.J. -- Drugmaker Eisai Inc. said the Food and Drug Administration approved a new, longer dosing regimen of its bone marrow disease treatment Dacogen. Eisai said the FDA cleared a five-day regimen of Dacogen as a treatment for myelodysplastic syndrome. Myelodysplastic syndrome affects the production of blood cells.

3/12/10 - FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS)

WOODCLIFF LAKE, N.J., March 11Eisai Inc. today announced that the U.S. Food and Drug Administration has approved a five-day dosing regimen for DacogenÂ® for Injection to treat patients with myelodysplastic syndromes, a group of bone marrow diseases that alter the production of functional blood cells.

3/12/10 - Rex Medical wins FDA clearance for new rotational thrombectomy system

Rex Medical, a medical device company, has received 510 clearance from the FDA for the Cleaner rotational thrombectomy system. Cleaner technology is indicated for mechanical declotting of occluded native vessel dialysis fistulae and synthetic dialysis access grafts, Rex Medical said.

Chain Drug Review

Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.

Featured Article from Chain Drug Review:

AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more